CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Mud therapy

Effect of mud compress therapy on cartilage destruction detected by CTX-II in patients with knee osteoarthritis.

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

Effect of mud compress therapy on cartilage destruction detected by CTX-II in patients with knee osteoarthritis.

Abstract Source:

J Back Musculoskelet Rehabil. 2015 Sep 6. Epub 2015 Sep 6. PMID: 26406208

Abstract Author(s):

Gonca Odemis Gungen, Fusun Ardic, Gulin Findikoglu, Simin Rota

Article Affiliation:

Gonca Odemis Gungen

Abstract:

BACKGROUND/OBJECTIVE: The aim of this study is to investigate the effect of mud compress (MC) therapy compared to hot pack (HP) therapy on cartilage destruction and subchondral bone alterations detected by urine levels of C telopeptide fragment of collagen type-II (uCTX-II) in patients with knee osteoarthritis (OA).

METHODS: Fifty-nine patients between 49-74 years of age with bilateral knee OA divided into 2 groups. Twenty-five patients (16 females, 9 males) and 34 patients (22 females, 13 males) were given HP and local natural organic and mineral-rich MC therapy respectively for 2 weeks as a total of 12 sessions. uCTX-II, Visual Analog Scale (VAS), 15 m walking time, Western Ontario and McMaster Universities multifunctional (WOMAC) index were measured at baseline, after-treatment and 3 months after treatment.

RESULTS: uCTX-II level did not show any difference between the two groups, however it decreased significantly in MC and HP groups 3 months after treatment (p<0.017). WOMAC stiffness sore was significantly lower in MC group 3 months after treatment (p<0.05). Both MC and HP therapies lowered VAS, WOMAC total and subscores significantly up to 3 months (p<0.017).

CONCLUSIONS: HP and MC therapies for OA of knee are not superior to one another with respect to the level of uCTX-II. MC may probably decrease the ongoing cartilage destruction and related subchonral bone interactions earlier compared to HP treatment in patients with knee OA as evidenced by decreased uCTX-II levels after-treatment.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.